UPDATE: JP Morgan Downgrades CME Group to Underweight on Falling Volumes
JP Morgan reduced its rating on CME Group (NASDAQ: CME) from Neutral to Underweight and reduced its price target from $56.50 to $54.
JP Morgan said, "We see a disconnect between the fundamentals in CME's core business and the price appreciation and valuation of its stock. While we see the opportunities for both OTC clearing revenue and the migration to listed trading for interest rates, we feel that those opportunities could develop over a longer period of time, leaving investors to focus on the market-condition-driven deterioration in volumes. While a special dividend provides support to the stock, we see the potential for downside with limited upside over the next 6-12 months."
CME Group closed at $59.35 on Thursday.
Latest Ratings for CME
|Apr 2016||Keefe Bruyette & Woods||Maintains||Market Perform|
|Mar 2016||JP Morgan||Maintains||Neutral|
|Feb 2016||Deutsche Bank||Maintains||Buy|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.